Literature DB >> 24067269

Lung cancer: needs assessment, treatment and therapies.

Michael Evans1.   

Abstract

Lung cancer is the most common cancer in the world. Globally, the annual diagnosis rate of new cases is approximately 1.6 million. The latest figures for the UK show that there are approximately 39000 cases each year and that lung cancer accounts for about 22% of all cancer deaths (Cancer Research UK, 2013a). This article will look at the latest national recommendations for managing and treating non-small cell lung cancer, which accounts for about 80% of lung cancers, as well as emerging therapies. It is not within the scope of this article to discuss each type and aspect of lung cancer in detail and further reading is encouraged.

Entities:  

Mesh:

Year:  2013        PMID: 24067269     DOI: 10.12968/bjon.2013.22.Sup17.S15

Source DB:  PubMed          Journal:  Br J Nurs        ISSN: 0966-0461


  19 in total

1.  SP1-induced overexpression of LINC00520 facilitates non-small cell lung cancer progression through miR-577/CCNE2 pathway and predicts poor prognosis.

Authors:  Ji-Fang Wang; Zhuo-Na Xi; Hong-Jian Su; Zhen Bao; Ya-Hong Qiao
Journal:  Hum Cell       Date:  2021-03-11       Impact factor: 4.174

2.  Interleukin-22 enhances chemoresistance of lung adenocarcinoma cells to paclitaxel.

Authors:  Zhiliang Huang; Yu Gao; Dianchen Hou
Journal:  Hum Cell       Date:  2020-05-25       Impact factor: 4.174

Review 3.  Association of CYP1B1 Leu432Val polymorphism and lung cancer risk: an updated meta-analysis.

Authors:  Xianjun Lao; Xue Qin; Qiliu Peng; Zhiping Chen; Yu Lu; Yanqiong Liu; Shan Li
Journal:  Lung       Date:  2014-07-03       Impact factor: 2.584

4.  mRNA and microRNA expression profiles of radioresistant NCI-H520 non-small cell lung cancer cells.

Authors:  Wei Guo; Li Xie; Long Zhao; Yuehuan Zhao
Journal:  Mol Med Rep       Date:  2015-04-08       Impact factor: 2.952

5.  AAV-Mediated angiotensin 1-7 overexpression inhibits tumor growth of lung cancer in vitro and in vivo.

Authors:  Xinglu Chen; Sansan Chen; Nana Pei; Yingying Mao; Shengyao Wang; Renhe Yan; Na Bai; Andrew Li; Yanling Zhang; Hongyan Du; Baihong Chen; Colin Sumners; Jinlong Li; Hongwei Li
Journal:  Oncotarget       Date:  2017-01-03

6.  Circulating exosomes contain protein biomarkers of metastatic non-small-cell lung cancer.

Authors:  Ning Wang; Xingguo Song; Lisheng Liu; Limin Niu; Xingwu Wang; Xianrang Song; Li Xie
Journal:  Cancer Sci       Date:  2018-04-15       Impact factor: 6.716

7.  Anti-tumor effect of chitin oligosaccharide plus cisplatin in vitro and in vivo.

Authors:  Xing Liu; Yan Zhang; Zhaozhe Liu; Xiaodong Xie
Journal:  Onco Targets Ther       Date:  2019-09-16       Impact factor: 4.147

8.  Video-assisted thoracoscopic surgery versus muscle-sparing thoracotomy for non-small cell lung cancer: a systematic review and meta-analysis.

Authors:  Zihuai Wang; Long Pang; Jiexi Tang; Jiahan Cheng; Nan Chen; Jian Zhou; Lunxu Liu
Journal:  BMC Surg       Date:  2019-10-15       Impact factor: 2.102

9.  Temozolomide-perillyl alcohol conjugate induced reactive oxygen species accumulation contributes to its cytotoxicity against non-small cell lung cancer.

Authors:  Xingguo Song; Li Xie; Xingwu Wang; Qian Zeng; Thomas C Chen; Weijun Wang; Xianrang Song
Journal:  Sci Rep       Date:  2016-03-07       Impact factor: 4.379

Review 10.  Na/K Pump and Beyond: Na/K-ATPase as a Modulator of Apoptosis and Autophagy.

Authors:  Cassiano Felippe Gonçalves-de-Albuquerque; Adriana Ribeiro Silva; Camila Ignácio da Silva; Hugo Caire Castro-Faria-Neto; Patrícia Burth
Journal:  Molecules       Date:  2017-04-21       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.